Xenical Articles
Roche Nearer To Obesity Drug Approval
19 May 1997
European And London Stock Comment
24 April 1997
Roche Enters New Product Phase With Bright Prospects
17 February 1997
Roche Impresses At Analysts' Meeting
17 February 1997
Millennium And Roche See Progress In Obesity Research
27 January 1997
Roche's 1996 Sales Ahead Of Expectations
27 January 1997
Roche Files For Orlistat
9 December 1996
Alizyme Details R&D Strategy And Pipeline
18 November 1996
Roche Highlights Obesity Drug At R&D Conference
21 October 1996
Sales Team Expands At Bristol-Myers Squibb
16 September 1996
1996 First-Half Sales In Line At Roche
22 July 1996
Redux Approved In The USA; Launch In June
6 May 1996
Brussels Probes Roche Austrian "Subsidy"
4 March 1996
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
